American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Return to Cancer Screening Quality Improvement Project and Clinical Study Now Available

We are pleased to announce that an elective Plan/Do/Study/Act (PDSA) 2021 quality improvement project and clinical study are now available for all Commission on Cancer (CoC) and National Accreditation Program for Breast Centers (NAPBC) sites who wish to participate.

Cancer screening is an important component of cancer care and is part of the CoC and NAPBC standards. The COVID-19 pandemic has substantially disrupted cancer screening due to the: (1) closing of facilities that conduct screening; (2) decrease in availability of staff to support screening; (3) lack of patient awareness that screening is safe when precautions are taken; (4) backlog causing scheduling delays; (5) and traditional in-person screening events may not have been permissible or safe due to the pandemic. The American College of Surgeons Cancer Programs, with support from the American Cancer Society, is pleased to provide this opportunity for CoC and NAPBC programs to lead efforts to improve cancer screening and care in their communities.

We created a PDSA quality improvement project and a clinical study.

  • It is elective; you do not have to participate.
  • It is intended to help use existing materials to accelerate return to screening.
  • Completing the PDSA project will fulfill CoC Standard 8.3 (cancer screening event) and NAPBC Standard 4.1 (education, prevention, and early detection programs).
  • Completing the PDSA project will fulfill CoC Standard 7.3 (quality improvement initiative) and NAPBC Standard 6.1 (quality and outcomes).
  • Completing the IRB exempt clinical study will provide local PI status, publication authorship, and part or full credit for CoC Standard 9.1 (clinical research accrual) and NAPBC standard 3.2 (clinical trial accrual).
  • CoC and NAPBC-accredited programs can participate in the PDSA only, or in the PDSA and clinical study.
  • Completing forms A, B, and C will be required in order for programs to achieve compliance with CoC Standards 7.3, 8.3, and 9.1 and NAPBC Standards 3.2, 4.1, and 6.1.
  • Programs are welcome to use the information and interventions without completing and submitting the PDSA or clinical study forms, but they will not be eligible to receive credit for CoC Standards 7.3, 8.3, and 9.1 and NAPBC Standards 3.2, 4.1, and 6.1.

We hope this quality improvement project and clinical research study will help your program to curtail the rising cancer burden in your local community that has been brought on by the pandemic. Additional information about the project and study is available on the ACS website. Download the full details about the PDSA project and study.

Funding Opportunities Available through National Surgeon Scientist Program

The American College of Surgeons (ACS) National Surgeon Scientist Program (NSSP) will provide competitive funding opportunities for faculty members within their first one to five years of appointment and whose research focus is on a cancer-related disease and is basic or translational science research. The purpose of this initial funding is to create a pilot developmental program for surgeon scientists that ultimately will develop into a broader and more comprehensive program. The future program will provide a cohort of academic surgeons structured mentorship and professional development in order to increase the pipeline of successful, independent surgeon investigators. Strong consideration will be given to individuals who are in a strong academic research environment with documented departmental research support and whose projects are particularly innovative. Additional information, including applicant requirements, is available on the ACS website.